Tibolone associated with increased endometrial cancer risk?

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2005

Schlagwörter:	Endometrial Cancer Adjust Odds Ratio Practice Research Research Database Incidence Rate Ratio

Anmerkung:	© Adis International Ltd 2005

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1480-1481(2005), 1 vom: März, Seite 20-20
Übergeordnetes Werk:	volume:1480-1481 ; year:2005 ; number:1 ; month:03 ; pages:20-20

Links:	Volltext

DOI / URN:	10.2165/00128413-200514800-00045

Katalog-ID:	SPR035213175

Internformat


LEADER	01000caa a22002652 4500
001	SPR035213175
003	DE-627
005	20230519073810.0
007	cr uuu---uuuuu
008	201007s2005 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200514800-00045 \|2 doi
035			\|a (DE-627)SPR035213175
035			\|a (SPR)00128413-200514800-00045-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Tibolone associated with increased endometrial cancer risk?
264		1	\|c 2005
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2005
650		4	\|a Endometrial Cancer \|7 (dpeaa)DE-He213
650		4	\|a Adjust Odds Ratio \|7 (dpeaa)DE-He213
650		4	\|a Practice Research \|7 (dpeaa)DE-He213
650		4	\|a Research Database \|7 (dpeaa)DE-He213
650		4	\|a Incidence Rate Ratio \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1480-1481(2005), 1 vom: März, Seite 20-20 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1480-1481 \|g year:2005 \|g number:1 \|g month:03 \|g pages:20-20
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200514800-00045 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 1480-1481 \|j 2005 \|e 1 \|c 03 \|h 20-20

Indexfelder

matchkey_str	article:22306056:2005----::iooesoitdihnraeedmt
hierarchy_sort_str	2005
publishDate	2005
allfields	10.2165/00128413-200514800-00045 doi (DE-627)SPR035213175 (SPR)00128413-200514800-00045-e DE-627 ger DE-627 rakwb eng Tibolone associated with increased endometrial cancer risk? 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Endometrial Cancer (dpeaa)DE-He213 Adjust Odds Ratio (dpeaa)DE-He213 Practice Research (dpeaa)DE-He213 Research Database (dpeaa)DE-He213 Incidence Rate Ratio (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1480-1481(2005), 1 vom: März, Seite 20-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1480-1481 year:2005 number:1 month:03 pages:20-20 https://dx.doi.org/10.2165/00128413-200514800-00045 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1480-1481 2005 1 03 20-20
spelling	10.2165/00128413-200514800-00045 doi (DE-627)SPR035213175 (SPR)00128413-200514800-00045-e DE-627 ger DE-627 rakwb eng Tibolone associated with increased endometrial cancer risk? 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Endometrial Cancer (dpeaa)DE-He213 Adjust Odds Ratio (dpeaa)DE-He213 Practice Research (dpeaa)DE-He213 Research Database (dpeaa)DE-He213 Incidence Rate Ratio (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1480-1481(2005), 1 vom: März, Seite 20-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1480-1481 year:2005 number:1 month:03 pages:20-20 https://dx.doi.org/10.2165/00128413-200514800-00045 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1480-1481 2005 1 03 20-20
allfields_unstemmed	10.2165/00128413-200514800-00045 doi (DE-627)SPR035213175 (SPR)00128413-200514800-00045-e DE-627 ger DE-627 rakwb eng Tibolone associated with increased endometrial cancer risk? 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Endometrial Cancer (dpeaa)DE-He213 Adjust Odds Ratio (dpeaa)DE-He213 Practice Research (dpeaa)DE-He213 Research Database (dpeaa)DE-He213 Incidence Rate Ratio (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1480-1481(2005), 1 vom: März, Seite 20-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1480-1481 year:2005 number:1 month:03 pages:20-20 https://dx.doi.org/10.2165/00128413-200514800-00045 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1480-1481 2005 1 03 20-20
allfieldsGer	10.2165/00128413-200514800-00045 doi (DE-627)SPR035213175 (SPR)00128413-200514800-00045-e DE-627 ger DE-627 rakwb eng Tibolone associated with increased endometrial cancer risk? 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Endometrial Cancer (dpeaa)DE-He213 Adjust Odds Ratio (dpeaa)DE-He213 Practice Research (dpeaa)DE-He213 Research Database (dpeaa)DE-He213 Incidence Rate Ratio (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1480-1481(2005), 1 vom: März, Seite 20-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1480-1481 year:2005 number:1 month:03 pages:20-20 https://dx.doi.org/10.2165/00128413-200514800-00045 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1480-1481 2005 1 03 20-20
allfieldsSound	10.2165/00128413-200514800-00045 doi (DE-627)SPR035213175 (SPR)00128413-200514800-00045-e DE-627 ger DE-627 rakwb eng Tibolone associated with increased endometrial cancer risk? 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Endometrial Cancer (dpeaa)DE-He213 Adjust Odds Ratio (dpeaa)DE-He213 Practice Research (dpeaa)DE-He213 Research Database (dpeaa)DE-He213 Incidence Rate Ratio (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1480-1481(2005), 1 vom: März, Seite 20-20 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1480-1481 year:2005 number:1 month:03 pages:20-20 https://dx.doi.org/10.2165/00128413-200514800-00045 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1480-1481 2005 1 03 20-20
language	English
source	Enthalten in Inpharma weekly 1480-1481(2005), 1 vom: März, Seite 20-20 volume:1480-1481 year:2005 number:1 month:03 pages:20-20
sourceStr	Enthalten in Inpharma weekly 1480-1481(2005), 1 vom: März, Seite 20-20 volume:1480-1481 year:2005 number:1 month:03 pages:20-20
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Endometrial Cancer Adjust Odds Ratio Practice Research Research Database Incidence Rate Ratio
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2005-03-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035213175
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035213175</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519073810.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2005 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200514800-00045</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035213175</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200514800-00045-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Tibolone associated with increased endometrial cancer risk?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2005</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2005</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endometrial Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adjust Odds Ratio</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Practice Research</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Research Database</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Incidence Rate Ratio</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1480-1481(2005), 1 vom: März, Seite 20-20</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1480-1481</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:1</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:20-20</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200514800-00045</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1480-1481</subfield><subfield code="j">2005</subfield><subfield code="e">1</subfield><subfield code="c">03</subfield><subfield code="h">20-20</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Tibolone associated with increased endometrial cancer risk? Endometrial Cancer (dpeaa)DE-He213 Adjust Odds Ratio (dpeaa)DE-He213 Practice Research (dpeaa)DE-He213 Research Database (dpeaa)DE-He213 Incidence Rate Ratio (dpeaa)DE-He213
topic	misc Endometrial Cancer misc Adjust Odds Ratio misc Practice Research misc Research Database misc Incidence Rate Ratio
spellingShingle	misc Endometrial Cancer misc Adjust Odds Ratio misc Practice Research misc Research Database misc Incidence Rate Ratio Tibolone associated with increased endometrial cancer risk?
topic_unstemmed	misc Endometrial Cancer misc Adjust Odds Ratio misc Practice Research misc Research Database misc Incidence Rate Ratio
topic_browse	misc Endometrial Cancer misc Adjust Odds Ratio misc Practice Research misc Research Database misc Incidence Rate Ratio
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Tibolone associated with increased endometrial cancer risk?
ctrlnum	(DE-627)SPR035213175 (SPR)00128413-200514800-00045-e
title_full	Tibolone associated with increased endometrial cancer risk?
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2005
contenttype_str_mv	txt
container_start_page	20
container_volume	1480-1481
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200514800-00045
title_sort	tibolone associated with increased endometrial cancer risk?
title_auth	Tibolone associated with increased endometrial cancer risk?
abstract	© Adis International Ltd 2005
abstractGer	© Adis International Ltd 2005
abstract_unstemmed	© Adis International Ltd 2005
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	1
title_short	Tibolone associated with increased endometrial cancer risk?
url	https://dx.doi.org/10.2165/00128413-200514800-00045
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200514800-00045
up_date	2024-07-03T13:53:25.455Z
_version_	1803566244648976384
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035213175</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519073810.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2005 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200514800-00045</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035213175</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200514800-00045-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Tibolone associated with increased endometrial cancer risk?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2005</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2005</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endometrial Cancer</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adjust Odds Ratio</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Practice Research</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Research Database</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Incidence Rate Ratio</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1480-1481(2005), 1 vom: März, Seite 20-20</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1480-1481</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:1</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:20-20</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200514800-00045</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1480-1481</subfield><subfield code="j">2005</subfield><subfield code="e">1</subfield><subfield code="c">03</subfield><subfield code="h">20-20</subfield></datafield></record></collection>
score	7.401602

Nicht das Richtige dabei?

Schreiben Sie uns!

Tibolone associated with increased endometrial cancer risk?

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?